Aquestive Therapeutics, Inc. · NASDAQ:AQST

Korczynski Sherry sold 8,750 Aquestive Therapeutics, Inc. shares (Form 4)

Traded Sep 9, 2026 · Filed Sep 11, 2026

On Sep 9, 2026, Korczynski Sherry (Chief Commercial Officer) sold 8,750 Aquestive Therapeutics, Inc. shares at US$5.22 for US$45,675 under a trading plan, leaving 235,689 shares. Filed Sep 11, 2026 (Form 4).

Sold
8,750 shares
Price
US$5.22
Value
US$45,675
Holding after
235,689 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 9, 2026Common StockOption exercise8,750US$2.65244,439Direct
Sep 9, 2026Common StockSale8,750US$5.22235,689Direct

Source

View original at SEC

Related